House
GuidelinesCalculatorsPricingBlog
Ask House ↗
Guidelines↗Calculators↗Pricing↗Blog↗
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
Back to guidelines
Gastroenterology

Management of Patients With Acute Lower Gastrointestinal Bleeding

ACG · 2023 edition / updateSource checked 29 October 2026
Read the source publication
House clinical summary

Scope

This ACG guide addresses acute colorectal bleeding in adults. It links resuscitation and selective anticoagulant reversal with choosing CT angiography or colonoscopy, then preventing recurrent bleeding without unnecessarily withholding cardiovascular protection. Many decisions rest on limited evidence and depend on bleeding severity, stability and local expertise.

Written by House with AI assistance · AI-assisted source check 29 October 2026.

This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.

Assess severity while resuscitating

  • Obtain a focused history, examination and laboratory assessment while resuscitating. Review antithrombotics and NSAIDs. Give intravenous fluid for instability or suspected ongoing bleeding, aiming to optimise blood pressure and heart rate before endoscopic intervention. [1]
  • Consider an upper gastrointestinal source when haematochezia accompanies haemodynamic instability; perform upper endoscopy if suspicion is high. Rectal bleeding does not itself establish a colorectal source. [1]
  • Consider an Oakland score of ≤8 to help identify low-risk patients for early discharge with outpatient investigation. This conditional, low-certainty recommendation supplements clinical judgement and requires an achievable follow-up plan. [1]
  • In haemodynamically stable LGIB, consider a restrictive red-cell transfusion threshold of haemoglobin 7 g/dL (conditional, low certainty). Significant ongoing bleeding or shock are exceptions; do not apply this stable-patient threshold mechanically during haemorrhagic shock. [1]

Reserve reversal for selected life-threatening bleeding

  • Most warfarin/VKA-associated LGIB does not need reversal. Consider reversal for life-threatening bleeding with INR substantially above the therapeutic range. For nonvalvular atrial fibrillation requiring VKA reversal, prefer four-factor PCC to fresh frozen plasma for rapid INR reduction (conditional, very low certainty). [1]
  • For DOAC-associated life-threatening LGIB unresponsive to initial resuscitation and withholding the anticoagulant, consider reversal. If taken within 24 hours, use available targeted agents: idarucizumab for dabigatran or andexanet alfa for apixaban/rivaroxaban. This is conditional, very low-certainty guidance for a small subset. [1]
  • In severe LGIB, maintain platelets above 30 × 10⁹/L; consider above 50 × 10⁹/L for endoscopic procedures. These are expert key concepts. Antiplatelet use alone does not justify routine platelet transfusion. [1]
  • Continue cardiac aspirin for secondary prevention during hospitalisation if possible. Initially hold nonaspirin antiplatelets in severe haematochezia, but use multidisciplinary assessment before interrupting treatment after a cardiac stent placed within 1 year. [1]
  • Do not give tranexamic acid or other antifibrinolytics for LGIB: ACG makes a strong recommendation against them, with moderate-certainty evidence. [1]

Choose the investigation for the current bleeding state

  • Consider CTA first for ongoing haemodynamically significant haematochezia (conditional, low certainty). Yield is low after bleeding subsides or with minor bleeding; a negative study may reflect intermittent bleeding. [1]
  • Refer promptly to interventional radiology for catheter arteriography and possible embolisation when CTA shows extravasation (strong, moderate certainty). An expert centre may instead consider colonoscopy after positive CTA. [1]
  • Perform colonoscopy for most hospitalised LGIB patients (strong, low certainty). It may be unnecessary when bleeding has stopped and a high-quality examination within 12 months showed diverticulosis without colorectal neoplasia; new symptoms suggesting another disease can still justify repeat examination. [1]
  • When inpatient colonoscopy is needed, use the next available nonemergent opportunity. Routine urgent colonoscopy within 24 hours has not improved rebleeding or mortality (strong, moderate certainty). This does not delay resuscitation or CTA for ongoing severe bleeding. [1]
  • Use bowel preparation for inpatient colonoscopy; split-dose and lower-volume preparations may be considered. Unprepared examination or routine sigmoidoscopy is inappropriate unless the source is known to arise from the anorectum or distal colon. [1]

Treat demonstrated bleeding and plan for recurrence

  • Treat active bleeding or stigmata of recent haemorrhage endoscopically. For diverticular stigmata, use through-the-scope clips, endoscopic band ligation or coagulation (strong, moderate certainty); the technique requires appropriate expertise. [1]
  • After rebleeding, consider repeat colonoscopy according to stability and the likelihood of successful treatment. Stable suspected recurrent diverticular bleeding after recent colonoscopy may be observed. For a known site refractory to endoscopic therapy, proceed to angiography with possible embolisation. [1]
  • Reserve surgery for failure of endoscopic or radiological treatment. If needed, make every effort to localise the source precisely so resection can be targeted rather than nonlocalised. [1]

Balance recurrent bleeding and vascular protection

  • After hospitalisation for diverticular haemorrhage, stop nonaspirin NSAIDs (strong, low certainty). This recommendation concerns recurrent diverticular bleeding prevention. [1]
  • After diverticular haemorrhage, consider stopping aspirin used solely for primary cardiovascular prevention, but continue aspirin for established cardiovascular disease. Both recommendations are conditional with low-certainty evidence and distinguish the cardiovascular indication. [1]
  • After diverticular haemorrhage, reassess the benefits and risks of nonaspirin antiplatelets through a multidisciplinary decision rather than automatically discontinuing them (strong, low certainty). [1]
  • Resume anticoagulation after LGIB has ceased to reduce postbleeding thromboembolism and mortality (strong, moderate certainty). The optimum timing is uncertain; the discussion generally favours resumption within 7 days of the bleeding event, requiring an individual balance of bleeding control and thrombotic risk. [1]

Limitations and use

  • This is a focused adult acute colorectal-bleeding summary, not a small-bowel bleeding or comprehensive upper-GI bleeding protocol.
  • Reversal drug doses, procedural techniques and special cardiovascular transfusion thresholds require the full guideline and current local protocols. Reversal-agent availability and regulatory status vary.
  • Recommendations with low or very low certainty and ungraded key concepts should not be interpreted as proven superiority in every patient.

This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.

Summary sources

  1. 1
    Management of Patients With Acute Lower Gastrointestinal Bleeding

    Selected recommendation material consulted

Original guideline

Publication details

Issuing organisation
ACG
Resource type
Clinical guideline · House clinical summary

The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.

On this page

  • Scope
  • Assess severity while resuscitating
  • Reserve reversal for selected life-threatening bleeding
  • Choose the investigation for the current bleeding state
  • Treat demonstrated bleeding and plan for recurrence
  • Balance recurrent bleeding and vascular protection
  • Limitations and use
  • Summary sources
  • Publication details
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House